AR081220A1 - Uso de teriflunomida para el tratamiento de la atrofia cerebral - Google Patents

Uso de teriflunomida para el tratamiento de la atrofia cerebral

Info

Publication number
AR081220A1
AR081220A1 ARP110101770A ARP110101770A AR081220A1 AR 081220 A1 AR081220 A1 AR 081220A1 AR P110101770 A ARP110101770 A AR P110101770A AR P110101770 A ARP110101770 A AR P110101770A AR 081220 A1 AR081220 A1 AR 081220A1
Authority
AR
Argentina
Prior art keywords
teriflunomide
treatment
brain atrophy
atrophy
brain
Prior art date
Application number
ARP110101770A
Other languages
English (en)
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of AR081220A1 publication Critical patent/AR081220A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de teriflunomida para tratar la atrofia cerebral en un paciente que lo necesita.
ARP110101770A 2010-05-26 2011-05-24 Uso de teriflunomida para el tratamiento de la atrofia cerebral AR081220A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34849410P 2010-05-26 2010-05-26
US38937510P 2010-10-04 2010-10-04
US39140010P 2010-10-08 2010-10-08

Publications (1)

Publication Number Publication Date
AR081220A1 true AR081220A1 (es) 2012-07-04

Family

ID=44211940

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101770A AR081220A1 (es) 2010-05-26 2011-05-24 Uso de teriflunomida para el tratamiento de la atrofia cerebral

Country Status (4)

Country Link
AR (1) AR081220A1 (es)
TW (1) TW201208674A (es)
UY (1) UY33411A (es)
WO (1) WO2011150014A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012061062A1 (en) * 2010-10-25 2012-05-10 Sanofi-Aventis U.S. Llc Use of teriflunomide for improving motor function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268382A (en) 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis

Also Published As

Publication number Publication date
UY33411A (es) 2011-12-30
TW201208674A (en) 2012-03-01
WO2011150014A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
ECSP24031979A (es) Compuestos terapéuticamente activos y sus métodos de uso
ECSP14017269A (es) Compuestos para tratar la atrofia muscular espinal
CU20120161A7 (es) 5-fluoro-1h-pirazolopiridinas sustituidas
AR089993A1 (es) Macrociclos peptidomimeticos
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
UY34165A (es) ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?.
CL2012003385A1 (es) Tratamiento para la incontinencia.
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
IL229474A0 (en) Cannabinoids for use in the treatment of neuropathic pain
CR20130464A (es) Inhibidores sustituidos de acetil-coa carboxilasa
BR112014013843A2 (pt) uso de dispositivos para o tratamento de doenças neurológicas
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
BR112014000634A2 (pt) métodos para tratamento de incontinência associada com atividade sexual
GT201400242A (es) "nuevos compuestos de pirazol"
FI20115165A0 (fi) Terapeuttisia ja diagnostisia menetelmiä
CO7121334A2 (es) Formulaciones vesiculares
BR112014000670A2 (pt) uso de compostos oligossacarídeo para a prevenção e tratamento de cicatrizes patológicas
ECSP17021138A (es) Compuestos de dipeptidil-cetoamida y su uso para el tratamiento y/o la prevención de la acumulación de grasa
AR081220A1 (es) Uso de teriflunomida para el tratamiento de la atrofia cerebral
AR082436A1 (es) Uso de teriflunomida para tratar la esclerosis multiple
IN2014KN01772A (es)
BR112014002806A2 (pt) uso cosmético oral e processo cosmético para tratar e/ou prevenir odor corporal
AR085305A1 (es) Uso de la teriflunomida para el tratamiento del deterioro cognitivo

Legal Events

Date Code Title Description
FB Suspension of granting procedure